We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$5.93B
AUM Growth
+$411M
Cap. Flow
+$220M
Cap. Flow %
3.71%
Top 10 Hldgs %
18.58%
Holding
2,656
New
107
Increased
1,107
Reduced
377
Closed
19

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.76M
2
AMZN icon
Amazon
AMZN
+$7.95M
3
DOW icon
Dow Inc
DOW
+$5.98M
4
META icon
Meta Platforms (Facebook)
META
+$4.77M
5
AAPL icon
Apple
AAPL
+$4.04M

Sector Composition

Rank Sector Weight
1 Technology 17.56%
2 Financials 14.09%
3 Healthcare 12.58%
4 Industrials 10.29%
5 Consumer Discretionary 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSLR
2576
DELISTED
VIVINT SOLAR, INC.
VSLR
$26K ﹤0.01%
+3,563
New +$22.5K
XERS icon
2577
Xeris Biopharma Holdings
XERS
$1.55B
$25.3K ﹤0.01%
+2,215
New +$23.3K
PCMI
2578
DELISTED
PCM, Inc
PCMI
$24.7K ﹤0.01%
+706
New +$20.8K
AMBR
2579
DELISTED
Amber Road Inc
AMBR
$24.4K ﹤0.01%
+1,866
New +$20.9K
SMHI icon
2580
SEACOR Marine Holdings
SMHI
$264M
$24.1K ﹤0.01%
+1,610
New +$22.2K
DNTH icon
2581
Dianthus Therapeutics
DNTH
$6.29B
$23.9K ﹤0.01%
+101
New +$25K
RFL icon
2582
Rafael Holdings
RFL
$103M
$23.9K ﹤0.01%
+842
New +$14.5K
ODT
2583
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$23.8K ﹤0.01%
+650
New +$15.6K
ZYNE
2584
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$23.7K ﹤0.01%
+1,751
New +$20.2K
GRTS
2585
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$23.6K ﹤0.01%
+2,122
New +$24.3K
CFMS
2586
DELISTED
Conformis, Inc. Common Stock
CFMS
$23.5K ﹤0.01%
+215
New +$17.7K
DSPG
2587
DELISTED
DSP Group Inc
DSPG
$23.4K ﹤0.01%
+1,631
New +$23.5K
CTO
2588
CTO Realty Growth
CTO
$819M
$23.4K ﹤0.01%
+1,444
New +$23.6K
KOD icon
2589
Kodiak Sciences
KOD
$2.72B
$23.2K ﹤0.01%
+1,986
New +$17.7K
CRNX icon
2590
Crinetics Pharmaceuticals
CRNX
$8.96B
$23.1K ﹤0.01%
+925
New +$22.9K
CVRS
2591
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$22.9K ﹤0.01%
+7,680
New +$19.2K
SNCR
2592
DELISTED
Synchronoss Technologies
SNCR
$22.8K ﹤0.01%
+320
New +$18.1K
UBX
2593
DELISTED
Unity Biotechnology
UBX
$22K ﹤0.01%
+232
New +$19.7K
KALV
2594
DELISTED
KalVista Pharmaceuticals
KALV
$22K ﹤0.01%
+992
New +$23.3K
TECX
2595
Tectonic Therapeutic
TECX
$720M
$21.9K ﹤0.01%
+112
New +$24.2K
TFSL icon
2596
TFS Financial
TFSL
$4.89B
$21.7K ﹤0.01%
1,199
IIIV icon
2597
i3 Verticals
IIIV
$323M
$21.6K ﹤0.01%
+734
New +$18.2K
FWONA icon
2598
Liberty Media Series A
FWONA
$23.7B
$21.6K ﹤0.01%
628
TEUM
2599
DELISTED
Pareteum Corporation
TEUM
$21.3K ﹤0.01%
+8,169
New +$32.3K
PETX
2600
DELISTED
Aratana Therapeutics, Inc.
PETX
$21.2K ﹤0.01%
+4,118
New +$18.5K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2019 Portfolio in Review

As of Q2 2019, Metropolitan Life Insurance Company (MetLife) held 2,656 positions worth $5.93B, up 7.5% from $5.52B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife) deployed $220M of net new capital in Q2 2019, opening 107 new positions and adding to 1,107 existing holdings. Its largest new stake was Dow Inc: 113,293 shares worth $5.59M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $9.22M trimmed.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2019 buy was Dow Inc: 113,293 shares worth $5.59M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q2 2019, an estimated $9.76M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $9.22M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Integrated Device Technology I in Q2 2019, selling an estimated $3.61M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $5.93B portfolio in Q2 2019.
  • Metropolitan Life Insurance Company (MetLife) opened 107 new positions and closed 19 in Q2 2019.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 7.5% quarter-over-quarter to $5.93B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2019, filed 14 Aug 2019.